In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011. - Wikidata - wikimedia - TriplyDB

In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.

In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.

http://www.wikidata.org/entity/Q34363461

about

In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.

http://www.wikidata.org/entity/Q34363461

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@ast

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@en

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@nl

type

label

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@ast

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@en

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@nl

prefLabel

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@ast

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@en

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@nl

P1433

Q34363461-35CB76A1-F99E-4C5B-8165-6F62B1ABD213

P1476

Q34363461-7F64B58A-F0B0-468E-9008-9805C5ACC589

P2093

Q34363461-049A3947-090D-4B88-8C4B-A44E12B88BFD

Q34363461-0753F668-1692-4C0C-A205-35D70ABD1AC7

Q34363461-13879A63-17FC-4A6E-A794-56BBF76BE11C

Q34363461-28C50DFE-5A37-4167-8C26-6EFD2B1675FA

Q34363461-7A7A8408-24E1-4096-ACA3-A454A9DB4E91

P2860

Q34363461-2C12A444-8322-4E79-AA69-64CE1F8366F5

Q34363461-2C80E8E6-E8A5-4F77-BF27-B68FE1B293AE

Q34363461-3AEE0A42-2D2E-4331-B527-7A77B4E5E43B

Q34363461-6997AB28-D359-4E04-9ACC-CA14264ABE45

Q34363461-7B9211F2-4C59-4215-A4A2-7D17AB0D8664

Q34363461-8B6A6632-2A76-45B6-8493-199B03507B0D

Q34363461-95AE0336-01A5-4A6B-B2D2-E885AE1E51AE

Q34363461-A7E999AD-A066-4907-A370-1978D3A3173A

Q34363461-BBAD8BE3-BDB6-4904-BEA8-79AE50334C43

Q34363461-E4A55434-7966-4919-AC7A-49DDDE2BC08C

P2888

Q34363461-BD23445C-A47B-4D48-9EA1-D8029DAA61FA

P304

Q34363461-74B910F5-9786-444D-A685-6283D9D5BB06

P31

Q34363461-B7227745-9362-4614-A4E4-80A2A700E60E

P356

Q34363461-B7680AC8-D48B-4D99-8F45-8221AFE9AF84

P433

Q34363461-AB3B0F36-8C20-48FE-B7AD-F328EE2D845B

P478

Q34363461-169C3661-CB5F-4DBE-BAA9-42559BCBB4ED

P50

Q34363461-E3693B7D-4419-437A-A247-5D91393C0F82

Q34363461-F2F4B482-87E1-4F75-A049-67F0DFD41CF6

P577

Q34363461-A52281C9-0F27-4980-A7D4-25872F8974DC

P5875

Q34363461-D6D1C278-EFAD-4ED1-B73B-8FF91A1266EC

P6179

Q34363461-2A546D56-248F-4D83-977C-E86410B7F44F

P698

Q34363461-EFD2AE2A-9FE0-466E-8CCA-68059ECF0042

P932

Q34363461-E0A67FD8-E6D4-481F-A3C0-D20EF6B08EE3

P356

S00284-014-0622-8

P1433

Current Microbiology

P1476

In vitro activity of new cepha ...... rveillance Network: 2008-2011.

@en

P2093

Canadian Bacterial Surveillance Network (CBSN)

http://www.w3.org/2001/XMLSchema#string

Karen Green

http://www.w3.org/2001/XMLSchema#string

Samir N Patel

http://www.w3.org/2001/XMLSchema#string

Sylvia Pong-Porter

http://www.w3.org/2001/XMLSchema#string

Wallis Rudnick

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.

What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).

Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.

Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program.

Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae.

In vitro activity of ceftaroline, ceftobiprole and cethromycin against clinical isolates of Streptococcus pneumoniae collected from across Canada between 2003 and 2008.

Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).

P2888

s00284-014-0622-8

P304

763-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00284-014-0622-8

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264642138

http://www.w3.org/2001/XMLSchema#string

P6179

1020929982

http://www.w3.org/2001/XMLSchema#string

P698

25023636

http://www.w3.org/2001/XMLSchema#string

P932

4201750

http://www.w3.org/2001/XMLSchema#string